Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19-Reference-Cited by-同舟云学术

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19

Author:

Irie Kei¹²,Nakagawa Atsushi³,Fujita Hirotoshi¹,Tamura Ryo¹,Eto Masaaki⁴,Ikesue Hiroaki¹,Muroi Nobuyuki¹,Tomii Keisuke³,Hashida Tohru¹

Affiliation:

1. Department of Pharmacy Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan

2. Department of Pharmaceutics Faculty of Pharmaceutical Science Kobe Gakuin University Kobe Japan

3. Department of Respiratory Medicine Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan

4. Department of Clinical Laboratory Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference25 articles.

5. Coronavirus COVID‐19 Global Cases by Johns Hopkins The Center for Systems Science and Engineering (CSSE). . Accessed April 28 2020.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Application of Machine Learning in Pharmacometabolomics;2023 International Conference on Applied Physics and Computing (ICAPC);2023-12-27